PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 49: Articles 24001-24500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception and the "high-risk" woman.
  2. Contraception and the skin.
  3. Contraception and the young [editorial]
  4. Contraception and the young.
  5. Contraception and toxic-shock syndrome: a reanalysis.
  6. Contraception as a determinant factor in Colombian fertility. [La anticoncepcion como factor condicionante de la fecundidad en Colombia.]
  7. Contraception before and after induced abortion (author's transl) [Contraccezione prima e dopo l'I.V.G.]
  8. Contraception by intrauterine device. [La contraception par dispositif intra-uterin.]
  9. Contraception by means of intratubal medical devices?] [Answer to question. [Antikonzeption durch intratubare Metalldichtungen?]
  10. Contraception during lactation. [Kontrazeption in der Stillperiode.]
  11. Contraception during lactation: considerations in advising the individual or family planning program.
  12. Contraception during lactation: doctors' world-wide practice.
  13. Contraception for adolescents. [La contraception chez l'adolescente.]
  14. Contraception in diabetics [letter]
  15. Contraception in France: 1968-1980 (author's transl) [La contraception en France 1968-1980.]
  16. Contraception in the future.
  17. Contraception in the Republic of Argentina: intrauterine methods. [Anticoncepcion en la Republica Argentina: metodos intrauterinos.]
  18. Contraception with LHRH agonists, a new physiological approach.
  19. Contraception with Monogest in young women. [Antikoncepce Monogestem u mladych zen.]
  20. Contraception with subcutaneous capsules containing ST-1435. Pituitary and Ovarian function and plasma levels of ST-1435.
  21. Contraception--a woman's dilemma.
  22. Contraception-abortion lifeline.
  23. Contraception.
  24. Contraception.
  25. Contraception. 4th rev. Hungarian ed.
  26. Contraception: a guide to birth planning methods.
  27. Contraception: techniques, indications and complications. [Contraception: techniques, indications, et complications.]
  28. Contraceptive adoption following abortion in developing countries.
  29. Contraceptive behaviour of vasectomy acceptors.
  30. Contraceptive choices for lactating women: suggestions for postpartum family planning.
  31. Contraceptive choices of female university students.
  32. The contraceptive context: a model for increasing nursing's involvement in family health.
  33. Contraceptive development.
  34. The contraceptive effect of breastfeeding.
  35. Contraceptive effectiveness in delaying a birth: the Malaysian experience.
  36. Contraceptive effects of recent potent LHRH antagonist analogs.
  37. Contraceptive efficacy of 200 mcg R2323 and 10 mcg R2858.
  38. Contraceptive embarrassment and contraceptive behavior among young single women.
  39. Contraceptive evaluation.
  40. Contraceptive failure and continuation among married women in the United States, 1970-76.
  41. Contraceptive failure in a college population.
  42. Contraceptive foams and birth defects.
  43. Contraceptive methods and abortion: one question. [Methodes contraceptives et avortement: une question.]
  44. Contraceptive methods. [Metodos anticonceptivos.]
  45. Contraceptive non-use among women who do not intend to have any more children: Colombia and Costa Rica.
  46. Contraceptive patterns of college students who experienced early coitus.
  47. Contraceptive pills and acute pancreatitis.
  48. Contraceptive pills: where do we go from here? Tenth World Congress of Fertility and Sterility.
  49. Contraceptive practice and community-based distribution program impact in northeast Brazil.
  50. Contraceptive practice.
  51. Contraceptive practices of 1,486 women at the time of the first act of intercourse.
  52. Contraceptive Prevalence Survey, Piaui-1979. [Pesquisa sobre saude materno infantil e planejamento familiar Piaui-1979.]
  53. Contraceptive prevalence surveys in Colombia, summary of experiences. [Las encuestas del uso de anticoncepcion en Colombia, resumen de experiencias.]
  54. The contraceptive regimen as a medical regimen: implications for health education.
  55. Contraceptive research [letter]
  56. Contraceptive research [letter]
  57. Contraceptive research: the authors reply [Letter]
  58. Contraceptive retail sales programme in Sri Lanka.
  59. Contraceptive retail sales--Nepal second marketing plan.
  60. Contraceptive sponge found to be effective.
  61. Contraceptive sterilization: a comparison between Mexican Americans and Anglos living in U.S. counties bordering Mexico.
  62. Contraceptive usage, fertility and family structure in Pakistan.
  63. Contraceptive use among family planning clinic personnel.
  64. Contraceptive use and fertility in the Republic of Panama.
  65. Contraceptive use by adolescents: what do we know about Chicanas?
  66. Contraceptive use in Java-Bali: a multivariate analysis on the determinants of contraceptive use.
  67. Contraceptive use in Sri Lanka.
  68. The contraceptive use of Buserelin, a potent LHRH agonist: clinical and hormonal findings.
  69. Contraceptive utilization, United States, 1976.
  70. Contraceptives and the liver (author's transl) [Kontrazeptiva und Leber.]
  71. Contraceptives in sickle cell disease.
  72. Contraceptives, lipids and lipoproteins: a preliminary report.
  73. Contraceptives: back to the barriers.
  74. Contraindications to the use of oral contraceptives and indications for their use in adolescence, puerperium, and in menopause. [Controindicazioni all'uso dei contraccettivi orali e loro indicazioni nell'adolescenza, in puerperio ed in climaterio.]
  75. The contribution of ultrasonography to intrauterine contraception.
  76. The copper-7 intrauterine contraceptive device: 5-year evaluation.
  77. Correcting contraceptive failure rates for sample composition and sample selection bias.
  78. The correlation between prevalence of contraceptive use, population growth rates and crude birth rates.
  79. Cost analysis of the Danfa (Ghana) Project family planning component.
  80. A cost-benefit analysis of the proposed Jamaican Family Planning Project.
  81. Cost-benefit/effectiveness analysis -- experiences in Indian family planning program.
  82. The cost-effectiveness of a community-based social marketing project in Thailand: the Family Planning Health and Hygiene Project.
  83. Cost-effectiveness of family planning services in the SINAPS Primary Health Care Program.
  84. Cost-effectiveness of family planning: overview of the literature.
  85. Costs of contraception: detailed review of monetary and health costs.
  86. Counselling of contraceptive technology.
  87. A cross-cultural study of menstrual cycle characteristics of women practicing the sympto-thermal method of natural family planning.
  88. Current interest in vaginal contraception.
  89. The current status of contraception in France. [Le point sur la contraception en France.]
  90. Current trends in male contraception.
  91. Cystic disease, family history of breast cancer, and use of oral contraceptives.
  92. Czech women rely on contraception, abortion to keep families small.
  93. Data and analyses for 1980 revision of DHHS five-year plan for family planning services.
  94. Decision making in family planning. A field study of voluntary family planning centers in Menia City.
  95. The decision to breast feed--the role of the family planning clinic.
  96. Demographic and contraceptive patterns among Kenyan women: 1977-1978.
  97. Demographic and psychosocial correlates associated with the acceptability of implant method of contraception in comparison with copper T intra uterine device.
  98. Demographic change, family planning and population policy in Costa Rica. [Dinamica demografica, planificacion familiar y politica de poblacion en Costa Rica.]
  99. The demographic impact of 2 contraceptive service projects in Matlab Thana of Bangladesh: a compendium of findings for the 1975-1980 period.
  100. The demographic impact of a maternal and child health family planning project in Bangladesh.
  101. The demographic impact of two contraceptive service projects in Matlab Thana of Bangladesh.
  102. Depo-Provera: an injectable contraceptive.
  103. Depo-provera: the extent of the problem--a case study in the politics of birth control.
  104. Depo-Provera: the extent of the problem; a case study in the politics of birth control.
  105. Depressed PHA--induced lymphocyte transformation in women taking oral contraceptives.
  106. Depression, pyridoxine and oral contraception (author's transl) [Troubles de l'humeur, pyridoxine et contraception orale.]
  107. Description and some experiences of the National Survey of Prevalence of Use of Contraception Methods in Mexico (1979) [Descripcion y algunas experiencias de la Encuesta Nacional de Prevalencia en el Uso de Metodos Anticonceptivos en Mexico (1979)]
  108. Detection of N-acetylneuraminic acid with long-time application of hormonal contraceptives (author's transl) [Zum Nachweis von N-Azetylneuraminsaeure bei Langzeitapplikation hormonaler Kontrazeptiva.]
  109. Determinants of contraceptive use and methods in Colombia: an analysis of WFS data.
  110. Determinants of contraceptive use in Bangladesh.
  111. Development and testing of an educational slide program on natural family planning.
  112. Development of a male contraceptive: a beginning [editorial]
  113. The development of a training program in the use of mobile family planning and nutrition education units in Jamaica.
  114. The development of population and family planning programs in Somalia: an assessment of initiatives and assistance.
  115. Diagnostic study of population growth rate, and family planning in Tamil Nadu in a developmental perspective. Structured questions for interviewing the Director of Medical Services and Family Welfare, Tamil Nadu.
  116. Differentials in contraceptive knowledge in Nepal.
  117. Differentials in contraceptive use failure among married women aged 15-44 years: United States 1970-76.
  118. Differentials in contraceptive use failure among married women aged 15-44 years: United States l970-76. [Tables]
  119. Dilatation of hepatic sinusoids after use of oral contraceptives (author's transl) [Erweiterung der Lebersinusoide nach Anwendung oraler Kontrazeptiva.]
  120. Directory of contraceptives. Repertoire des contraceptifs. Guia de anticonceptivos, 1981.
  121. A dirty, filthy book: the writings of Charles Knowlton and Annie Besant on reproductive physiology and birth control and an account of the Bradlaugh-Besant trial.
  122. The discovery and use of evaluation knowledge in a regional family planning program.
  123. Discussion: physiology and contraceptive effects of LHRH and analogs in female animals: agonists.
  124. Discussion: physiology and contraceptive effects of LHRH and analogs in female animals: antagonists.
  125. Distribution of modern contraceptive use in a medium income rural population in Nigeria, in the absence of an adequate health care delivery system.
  126. Do hormonal contraceptives induce depression? [Hormonale Kontrazeptiva depressions-fordernd?]
  127. Does oral contraception cause deep venous thromboses? (author's transl) [Die hormonale Antikonzeption als Faktor bei der Eutstehung der akuten tiefen Venenthrombose.]
  128. The doubtful value of transitory contraception after laparoscopic electrocoagulation of the fallopian tubes.
  129. Dutch government aid to family planning reduces abortion use.
  130. Economic evaluation of the mother-child health/family planning project in Yozgat (author's transl) [Yozgat ana-cocuk sagligi/aile planlamasi projesi ekonomik degerlendirmesi.]
  131. Ectopic pregnancy and intrauterine contraceptive devices: new perspectives.
  132. Ectopic pregnancy in patients using intrauterine contraception.
  133. Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins.
  134. Effect of a low-estrogen contraceptive on physiologic variables.
  135. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
  136. Effect of antiepileptic drugs on estrogen and progesterone metabolism and on oral contraception.
  137. The effect of cigarette smoking on plasma concentrations of oral contraceptive steroids.
  138. Effect of combined contraceptive tablets on blood levels of the gonadotropic hormones estradiol and progesterone (author's transl) [A kombinalt fogamzasgatlo tablettak hatasa a gonadotrop hormonok, az osztradiol es progeszteron verszintjeire.]
  139. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin.
  140. Effect of contraceptives on the digestibility of dietary protein and nitrogen balance. [Einfluss von Kontrazeptiva auf die Verdaulichkeit des Nahrungsproteins und die N-Bilanz.]
  141. The effect of hormonal contraceptives on trace element levels of scalp hair. [Zum Einfluss hormonaler Kontrazeptiva auf den Spurenelementgehalt des Kopfhaares.]
  142. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
  143. The effect of oral contraceptive on serum bile acids and liver function routine tests.
  144. Effect of oral contraceptive use on ascorbic acid and vitamin A in lactation.
  145. Effect of oral contraceptives on antithrombin III.
  146. Effect of oral contraceptives on plasma immuno reactive insulin and carbohydrate levels.
  147. The effect of oral contraceptives on serum lipids, gamma-glutamyl transpeptidase, and excretion of d-glucaric acid.
  148. Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression.
  149. Effect of oral contraceptives on urinary porphyrins.
  150. The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity.
  151. The effect of the Philippine Family Planning Outreach Project on Contraceptive Prevalence.
  152. The effectiveness of contraceptive programs for teenagers.
  153. Effectiveness of the sympto-thermal method of natural family planning: an international study.
  154. The effectiveness of vaginal contraception: definitions and perspectives.
  155. The effectiveness of vaginal contraception: review of studies.
  156. The effects of a low-estrogen oral contraceptive on carbohydrate metabolism: a review of five studies.
  157. The effects of a low-estrogen oral contraceptive on pituitary and ovarian secretions: a review of three studies with a graded GnRF stimulation test.
  158. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
  159. Effects of combined oral contraceptives on metabolic processes. Final report (File No. 3-P-76-0185) submitted to IDRC.
  160. The effects of education on contraceptive use in Thailand.
  161. The effects of hormonal contraceptives on lactation: current findings, methodological considerations, and future priorities.
  162. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
  163. The effects of oral contraceptive pill on breast of mice.
  164. Effects of the Philippine Family Planning Outreach Project on contraceptive prevalence: a multivariate analysis.
  165. The effects of three different regimes of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women.
  166. Efficacy and safety of contraception with IUDs.
  167. Effort thrombosis of the subclavian vein associated with oral contraceptives.
  168. Eight additional urban family planning clinics. UNFPA Project ROK/77/P13. Progress/final report.
  169. Elaboration and development of a family planning program for pharmacists in Mexico. [Elaboracion y desarrollo de un programa de planificacion familiar a boticarios en Mexico.]
  170. Electrophoretic study on the changes of serum protein fractions in Korean women--the effects of age, oral contraceptive, and intrauterine contraceptive device (author's transl)
  171. Elevated beta-thromboglobulin levels associated with smoking and oral contraceptive agents in normal healthy women.
  172. Elevated prolactin levels in oral contraceptive pill-related hypertension.
  173. An empirical assessment of a decision making model of contraceptive use and nonuse among adolescent girls.
  174. Employee benefits for family planning in rural-based industries.
  175. Endocrine effects of combined oral contraceptive preparations.
  176. Endocrinological changes in depression caused by oral contraceptives.
  177. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
  178. Endometrial study (histopathological) and clinical complication in cases of oral contraceptives.
  179. Epidemiological studies of the long-term effects of birth control methods.
  180. Epistaxis secondary to oral contraceptive.
  181. Erythema nodosum and combined oral contraceptives. [Erytheme noueux et oestroprogestatifs.]
  182. Estrogens and postcoital contraception.
  183. Ethnic variation in adolescent use of a contraceptive service.
  184. Evaluating the Indonesian family planning story.
  185. Evaluation of distributors' knowledge of contraceptives in the Guatemalan CBD program.
  186. Evaluation of family planning in Thailand: the cost-effectiveness evaluation of Bangkok Metropolis' Family Planning Program in Thailand.
  187. Evaluation of I and E programmes: a study of PA Youth Training Camps on planned parenthood.
  188. An evaluation of the effects of strategies used to improve the delivery of rhythm as a family planning method [project proposal]
  189. An evaluation of the management components and administration of the Family Planning International Assistance grant (AID/pha-G-1131)
  190. Evaluation of the Philippine Family Planning Outreach Project.
  191. Evolution of plasmatic apolipoprotein B, cholesterol and triglyceride levels in fourty-five long-term combined oral contraceptive users (author's transl) [Evolution des taux plasmatiques de l'apolipoproteine B, du cholesterol et des triglycerides chez 45 femmes prenent des oestro-progestatifs contraceptifs oraux au long cours.]
  192. Evolution of the family planning program in Costa Rica. [Evolucion del programa de planificacion familiar en Costa Rica.]
  193. Evolution of the Korean family-planning system.

     

  194. Expansion of voluntary surgical contraception into rural, remote, and peripheral areas: report of an Expert Study Committee, Tunis, Tunisia, February 2-4, 1981.
  195. Experience in integrated social, health, and family planning services.
  196. Experience with a potent gonadotropin releasing hormone agonist in normal men: an approach to the development of a male contraceptive.
  197. Exploring risks and benefits of the birth control pill.
  198. Extracts from a report by the Delegation on Reproductive Physiology and Family Planning Techniques on its visit to the People's Republic of China, June 8-19, 1981.
  199. Factors affecting contraceptive use in Peninsular Malaysia.
  200. Factors affecting contraceptive use in Peninsular Malaysia.
  201. Factors affecting the duration of action of the injectable contraceptive norethisterone enanthate.
  202. The factors affecting the effectiveness of the basal body temperature method of birth control of the Natural Family Planning Clinic in Phillips Bukidnon and the surrounding areas.
  203. Factors associated with contraceptive use in Costa Rica.
  204. Factors associated with the acceptance and non-acceptance of family planning program among cultural minorities in Bukidnon, Philippines.
  205. Factors influencing birth control habits in Victoria.
  206. Facts about birth control pills.
  207. Failure of contraceptive steroids to modify human chorionic gonadotropin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture.
  208. Failure of oral contraceptive with rifampicin: a case report.
  209. Failure rates of contraceptive methods.
  210. Family composition, socioeconomic status, sexual and contraceptive knowledge, attitudes, and practices among black adolescent females.
  211. Family formation and birth control: behavior and attitudes: Colombia.
  212. Family formation and birth control: behaviour and attitudes: Egypt.
  213. Family formation and birth control: behaviour and attitudes: Pakistan.
  214. Family formation and birth control: behaviour and attitudes: Syrian Arab Republic.
  215. Family formation and contraception in selected developing countries: policy implications of WFS findings.
  216. The family planning "turntable": the counsellor in the face of a wide range of requests (author's transl) [Drehscheibe Familienplanung--die Rolle der Beraterin.]
  217. Family planning activities at People's Communes.
  218. Family planning along the U.S.-Mexico border [tables]
  219. Family planning and block grants.
  220. Family planning and educational level of the mother. [Familienplanung und Bildungsgrad der Mutter.]
  221. Family planning and family consolidation: field study in Assiut City.
  222. Family planning and family health.
  223. Family planning and fertility in Morocco.
  224. Family planning and population, Singapore: a bibliography with selected annotations.
  225. Family planning and the labor sector: soft-sell approach.
  226. The Family Planning Association of Hong Kong's Services for the mentally handicapped.
  227. Family Planning Association of Hong Kong. Follow-up study of sterilized female clients.
  228. Family planning campaign: a model for evaluation of its activity.
  229. Family planning communication campaigns.
  230. Family planning communications in El Salvador: current coverage and future directions.
  231. Family planning communications in Guatemala: a nationwide survey.
  232. Family planning concept.
  233. Family planning costs and benefits.
  234. Family planning for Mozambique.
  235. Family planning in Bangladesh.
  236. Family planning in Bicol and the Western Visayas in 1979: 1980 AFS.
  237. Family planning in Colombia: an analysis of cost and achievement.
  238. Family planning in Egypt.
  239. Family planning in Jendouba province: case study. Results of a project in family planning for the couple in a rural sector and of the Contraceptive Prevalence Survey in Jendouba. [Le planning familial dans le gouvernorat de Jendouba: etude de cas.]
  240. Family planning in Latin America: community and commercial programs. [Planificacion familiar en America Latina: Programas comunitarios y comerciales.]
  241. Family planning in rural Tunisia: a report on progress.
  242. Family planning in Shanghai County.
  243. Family planning in the 1980's: challenges and opportunities: recommendations of the International Conference on Family Planning in the 1980's.
  244. Family planning in the 1980's: review of the current status of family planning; annex to the background document.
  245. Family planning in the 1980s: challenges and opportunities.
  246. Family planning in the 80's.
  247. Family planning in the 80's: requisites for the future. Statement made at the International Conference on Family Planning in the 80's, Jakarta, Indonesia, 27 April 1981. [La planification familiale dans les annees 80: les conditions de son evolution. Planificacion familiar en los anos 80: requisitos parael futuro.]
  248. Family planning in the Philippines: a preliminary assessment of the impact of Population Planning II.
  249. Family planning in the United States: a perspective of the eighties.
  250. Family planning in Yugoslavia.
  251. The family planning information and service outlets.
  252. Family planning or life planning?
  253. Family planning outreach in the Philippines: final report on the Community Outreach Surveys.
  254. Family planning pioneering in Rhodesia (Zimbabwe) 1957-1970.
  255. Family planning practices among Indian couples in urban and rural sectors.
  256. Family planning practices and its impact on fertility in Maharashtra.
  257. Family planning program and genetics.
  258. The family planning program in Pakistan: what went wrong?
  259. The family planning programme--taxpayers can help and secure tax benefits.
  260. Family planning resources manual.
  261. Family planning service delivery as a policy strategy to reduce population growth rate: Phase II.
  262. Family planning service delivery in rural Tunisia: a case study.
  263. Family planning services for southeast Asian refugees.
  264. Family planning services in the private sector: a case study of Harrisons and Crosfield Estates in West Malaysia.
  265. Family planning services in the United States, 1978-1979.
  266. Family planning visits by teenagers: United States, 1978.
  267. Family planning, sterilization and abortion services.
  268. Family planning--a fundamental right of the individual and the society.
  269. Family planning--paragraph 218 StGB. [Familien planung--paragraph 218 StGB.]
  270. Family planning--social marketing.
  271. Family planning.
  272. Family planning.
  273. Family planning.
  274. Family planning.
  275. Family planning. [Planification familiale.]
  276. Family planning. [Planification familiale.]
  277. Family planning: footnote or theme?
  278. Family planning: an exercise in preventive medicine.
  279. Family planning: fundamentals for health professionals.
  280. Family planning: helping men ask for help.
  281. Family planning: its impact on the health of women and children.
  282. Family planning: maternal child health survey, Republic of Panama: 1979. Final report.
  283. Family planning: numbers game goes on.
  284. Fatal subarachnoid haemorrhage in young women: role of oral contraceptives.
  285. Female contraceptive potential of "super" agonists of LHRH as assessed in infrahuman primates.
  286. Fertility acceptance and natural family planning.
  287. Fertility and contraception in Costa Rica 1981: results of the second contraceptive prevalence survey. [Fecundidad y anticoncepcion en Costa Rica 1981: resultados de la segunda encuesta de prevalencia anticonceptiva.]
  288. Fertility and contraceptive usage in Mexico. [Fecundidad y uso de metodos anticonceptivos en Mexico.]
  289. Fertility and family planning behavior among Muslims: a study in a village in Andhra Pradesh.
  290. Fertility and family planning in Colombia: a Latin American example. [Fruchtbarkeit und Familienplanung in Kolumbien: ein lateinamerikanisches Beispiel.]
  291. Fertility and family planning in Indonesia: results of the National Socio Economic Survey, 1979. [Keterangan fertilitas dan keluarga berencana di Indonesia: hasil Survey Sosial Ekonomi Nasional 1979.]
  292. Fertility and family planning knowledge, attitudes and practice (KAP) in Central Luzon and Metro Manila: 1980 AFS.
  293. Fertility and family planning knowledge, attitudes and practice (KAP) in Central Luzon and Metro Manila: 1980 AFS.
  294. Fertility and family planning: Central Luzon and Metro Manila. 1980 AFS final report.
  295. Fertility control in India: natural family planning as an alternative strategy.
  296. Fertility preferences and contraceptive orientation in the Philippines.
  297. Fertility preferences and contraceptive use: a regional analysis.
  298. Fertility transition in a Balinese village, changing economic strategies and family planning. [Tables]
  299. Fertility, contraception and social classes. [Fecundidad, anticonception y clases sociales.]
  300. Fibrin and platelets in menstrual discharge before and after the insertion of an intrauterine contraceptive device.
  301. Field trials of family planning communication strategies in Venezuela, Kenya, and the Philippines: baseline survey report.
  302. Final report: evaluation of family planning services. Prepared for the Mali Ministry of Public Health and Social Affairs. [Rapport final: evaluation des services de planning familial. Prepare pour le Ministere de la Sante Publique et des Affaires Sociales du Mali.]
  303. The first abortion - and the last? A study of the personality factors underlying repeated failure of contraception.
  304. Fiscal accountability for family planning programs: a manual for national and regional managers.
  305. Five Year Plan for Family Planning (1982-1986)
  306. FPAP women's social development/family planning project Tajpur, (Sind.)
  307. Free thyroxine and free thyroxine index in women taking oral contraceptives.
  308. Further analyses of mortality in oral contraceptive users: Royal College of General Practitioners' Oral Contraception Study.
  309. General method for the assay of oral contraceptives by high-performance liquid chromatography.
  310. General overview: commercial programs of contraceptive distribution in Latin America. [Panorama general: programas de distribucion de anticonceptivos en America Latina.]
  311. General practitioners' contraceptive services: a postal survey in three study areas.
  312. General situation of family planning research in China.
  313. GnRH antagonists: physiologic and contraceptive application in the female rat.
  314. GPs and government clinics provide free family planning to over 70 percent of all UK women.
  315. Guangdong calls for stronger birth control effort.
  316. Guangdong holds meeting on planned parenthood.
  317. Guangdong official on planned parenthood rumors.
  318. Guangdong Prefecture's birth control efforts cited.
  319. Guatemala: community distribution of contraceptives. [Guatemala: distribution comunitaria de anticonceptivos.]
  320. Guide for promoting voluntary family planning 1981. [Guia del promotor voluntario de planificacion familiar 1981.]
  321. Guide to contraception. [Wallchart]
  322. Guidelines for contraception [Letter]
  323. Guidelines for contraception [letter]
  324. Guidelines for contraception.
  325. Guidelines for the clinical testing of male contraceptive drugs.
  326. Guidelines for women's bureaux and family planning association.
  327. Guizhou planned parenthood.
  328. Guo Feng attends birth control meeting.
  329. Haemophilus vaginalis (Corynebacterium vaginale, Gardnerella vaginalis) in a family planning clinic population.
  330. Haikou issues circular on planned parenthood.
  331. Haiti. Project paper. Family planning outreach.
  332. Haiti: a favorable context for family planning in one of the world's least developed countries.
  333. The harmful effects of common social habits, especially smoking and using oral contraceptive steroids, on pregnancy.
  334. Health rationale of surgical contraception.
  335. Health, nutrition, and family planning: a survey of experiments and special projects in India.
  336. Hepatic lesions caused by anabolic and contraceptive steroids.
  337. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.
  338. High density lipoprotein cholesterol and apolipoprotein A-I levels in 32-33-year-old women on steroid contraceptives--differences between two frequently used low-estrogen pills.
  339. Hint of government cutback in teen contraceptive services alarms MDs.
  340. Historical review of vaginal contraceptive methods.
  341. Hormonal contraception after evacuation of hydatid mole (author's transl) [Hormonalni antikoncepce po evakuaci moly hydatidozy.]
  342. Hormonal contraception and cancer. [Contraception hormonale et cancer.]
  343. Hormonal contraception and gynecological pathology other than genital cancers and mammary pathology. [Contraception hormonale et pathologie gynecologique en dehors des cancers genitaux et de la pathologie mammaire.]
  344. Hormonal contraception.
  345. Hormonal contraception: a warning for smokers. [Hormonhaltige Arzneimittel zur Schwangerschaftsverhutung: Warnhinweis fur Raucherinnen.]
  346. Hormonal contraceptives and the breast. [Contraceptifs hormonaux et sein.]
  347. Household distribution of contraceptives in Marrakech, Morocco. Final report.
  348. Household distribution of contraceptives in rural Haiti: the results and costs of the Division of Family Hygiene experimental project.
  349. Human and Christian endeavor in responsible parenthood and family planning. [Exercicio humano e Cristao da paternidade responsavel, planejamento familiar.]
  350. Hunan planned parenthood.

     

  351. Hyaluronidase inhibitors and contraception.
  352. Hypermenorrhagia in intrauterine contraception and pelvic inflammations. [Hypermenorhagia pri intrauterinni antikoncepci a panevni zanety.]
  353. Hypertension and oral contraceptives.
  354. Hypophyseal reaction state during oral contraception. [Die hypophysare Reaktionslage unter oralen Kontrazeptiva.]
  355. Idiopathic neonatal jaundice. 1. Influence of use of oral contraceptives before pregnancy and of smoking during pregnancy.
  356. Ileitis (probable Crohn's disease) and oral contraceptives (author's transl) [Ileite (maladie de Crohn probabale) et oestroprogestatifs.]
  357. Immune reactivity and the vascular risk in oral contraceptive users.
  358. Impact of contraceptive practice on child spacing. A life table analysis of birth intervals of urban and rural Thai women, 1979.
  359. Impact of contraceptive practice on child spacing. A life table analysis of birth intervals of urban and rural women, 1979.
  360. The impact of family planning programs on fertility in developing countries: a critical evaluation.
  361. The impact of Thailand's National Family Planning Program on fertility decline and the implications for short-run and long-run government expenditures.
  362. Impacts of peer counseling on teen contraception in Los Angeles.
  363. Impairment of antipyrine metabolism by low-dose contraceptive steroids.
  364. The importance of the results of the Haiti Fertility Survey for family planning in Haiti. [L'importance des resultats de l'enquete Haitienne sur la fecondite pour l'elaboration d'une planification familiale pour Haiti.]
  365. Impression of the Third Regional Training Course on the Control of Intestinal Helminthic Infections with Special Emphasis on Soil-transmitted Helminthiasis, Family Planning Practice and their Integrated Program.
  366. Improving delivery of rhythm as a family planning method [project proposal]
  367. In-service training on population/family planning information system, 19 May-9 July 1981, Bangkok.
  368. Inaugural address: the family planning activities of the Peruvian Ministry of Health. [Discurso de inauguracion: las actividades de planificacion familiar en el Ministerio de Salud del Peru.]
  369. Incidence of cerebrovascular lesions in users of oral contraceptives (author's transl) [Incidence cevnich lezicerebralnich pri uzivani peroralnich antikonceptiv.]
  370. The incidence of contraceptive use during lactation in the Third World.
  371. Incidence of ovarian cancer in relation to the use of oral contraceptives.
  372. Including men in family planning: new approaches.
  373. Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate.
  374. Indications, contraindications, and instructions for use of vaginal contraception.
  375. Indigenous contraception in Bangladesh: a preliminary survey.
  376. Induction of luteolysis by postovulatory intranasal administration of [D-Ser(TBU)6-des-Gly-NH210]-LHRH ethylamide (Buserelin): a postcoital contraceptive approach.
  377. The influence of a combined oral contraceptive pill and menstrual cycle phase on digital microvascular haemodynamics.
  378. The influence of gestagen-oriented oral contraceptives on the milk duct epithelium--cytological findings in mammary secretion. [Der Einfluss gestagenbetonter oraler Kontrazeptiva auf das Milchgangsepithel--Zytologische Befunds im Mammasekret.]
  379. The influence of hormonal oral contraception on the incidence of the carcinoma and dysplasia of cervix (author's transl) [Uticaj oralne hormonske kontracepcije na pojavu karcinoma i displazije cerviksa.]
  380. The influence of hormonal oral contraception on the incidence of the precancerous and cancerous lesions (author's transl) [Vpliv oralne hormonske kontracepcije na incidenco predrakavih in rakavih obolenj cerviksa.]
  381. The influence of oral contraception on the sex life of adolescents (author's transl) [Influence de la contraception orale sur la vie sexuelle des adolescents.]
  382. The influence of oral contraceptive therapy on the periodontium--duration of drug therapy.
  383. The influence of oral contraceptives and diet on ascorbic acid and vitamin A in lactation.
  384. Influence of oral contraceptives of differing dosages on alpha-1-antitrypsin, gamma-glutamyltransferase and alkaline phosphatase.
  385. The influence of pregnancy and contraceptive pills upon oxygen consumption during phagocytosis by human leukocytes.
  386. Influence of sex difference and oral contraceptives on forearm reactive hyperemia.
  387. The influence of the family planning program on the reduction of fertility in the Jakarta metropolitan region from 1971 to 1976. [Pengaruh program keluarga berencana terhadap penurunan fertilitas di DKI Jakarta tahun 1971-1976.]
  388. The influence of the presence of others during the interview on the reporting of contraceptive knowledge and use: a research note.
  389. Influence on intrauterine devices (IUDs) and contraceptive pills on blood loss in connection with a vacuum curettage.
  390. Inventory and characteristics of hormonal contraceptives in France. [Recensement et caracteristiques des contraceptifs hormonaux en France.]
  391. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Vol. 3.
  392. Investigation of the influence of oral contraceptives on premalignant and malignant lesions of the cervix. Final report.
  393. Isolated progestative contraception: advantages and disadvantages. [Contraception progestative isolee: avantages et inconvenients.]
  394. Issues in community-based distribution of contraceptives.
  395. Issues in integrated approaches to family planning programmes.
  396. Italian fertility and contraception.
  397. Jiangxi family planning.
  398. Jiangxi planned parenthood.
  399. Key issues in family planning in the 1980s.
  400. Kinship dependence and contraceptive use among Navajo women.
  401. Knowledge and beliefs about contraception among urban Bolivian women.
  402. Knowledge and social change: the case of family planning.
  403. Knowledge and use of contraception by individuals.
  404. Knowledge and utilisation pattern of MCH and family planning services in Lucknow city--salient findings of the survey.
  405. Knowledge of contraceptives: an assessment of World Fertility Survey data collection procedures.
  406. Knowledge, attitude, and practice of contraception: a survey of students at Terminale (the Classical Lycee in Abidjan) [Connaissance, attitude et pratique de la contraception: une enquete aupres des eleves de Terminale (Lycee Classique d'Abidjan)]
  407. Laboratory methods of detecting risk factors in women using oral contraceptives. [Laboratoriumsmethoden zur Erkennung von Risikofaktoren bei Frauen unter oraler Konaeption.]
  408. Latin America. Regional Seminar on Contraceptive Prevalence Surveys. Proceedings. November 8-13, 1981. [America Latina. Seminario Regional sobre las Encuestas de Prevalencia del Uso de Anticonceptivos. Actas. Noviembre 8-13 de 1981.]
  409. Launching a contraception campaign. Client: ASHONPLAFA (The Futures Group) [Campana lanzamiento anticonceptivos. Cliente: ASHONPLAFA (The Futures Group)]
  410. Legal abortion, family planning services largest factors in reducing U. S. neonatal mortality rate.
  411. Legal and policy aspects of contraceptive service delivery.
  412. Leukaemia and contraception.
  413. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
  414. LHRH analogues as contraceptives.
  415. Liu Jie attends Henan planned parenthood meeting.
  416. Liver rupture after prolonged use of contraceptive. [Leberruptur nach mehrjahriger hormonaler Kontrazeption.]
  417. Locus of control as related to birth control knowledge, attitudes and practices.
  418. Logistics guidelines for family planning programs.
  419. Long term follow up of children breastfed by mothers under different regimes of contraception, mechanical and hormonal: preliminary report.
  420. The long term safety of hormonal steroid contraceptives.
  421. A longitudinal study of fertility and family planning in a rural population, 1972-79.
  422. Low dose injectable contraceptive norethisterone enanthate 20 mg monthly. Pt. 1. Clinical trials.
  423. Low dose injectable contraceptive norethisterone enanthate 20 mg. monthly. Pt. 2. Metabolic side effects.
  424. Low serum creatine kinase values in contraceptive steroid users [letter]
  425. The magic of structure: a manual for planning and evaluating family planning education programs.
  426. Male concepts: on masculinity, parenthood and family planning.
  427. Male contraception in perspective (author's transl) [Les perspectives de contraception masculine.]
  428. Male contraception. [Contraception masculine.]
  429. Male contraceptives through the ages.
  430. Male hegemony in family planning.
  431. Male involvement in family planning: some approaches for FPAs.
  432. Male surgical contraception urological role: vas interruption and reversal.
  433. Malignant melanoma and oral contraceptives [letter]
  434. Management development in the Korean national family planning program.
  435. Management information and logistics in the Integrated Health and Family Planning Project of the Government of India: an assessment of needs.
  436. Management of masculinization with antiandrogen-containing contraceptive. [Androgenisatio tuneteinek befolyasolasa antiandrogen tartalmu fogamzasgatloval.]
  437. Marketing of social products: family planning in Bangladesh.
  438. Maternal and child health and family planning in Nigeria.
  439. Maternal child health--family planning survey. Pernambuco State, Brazil--1980.
  440. Maternal Child Health-Family Planning Survey Rio Grande do Norte, Brazil--1980.
  441. Maternal Child Health-Family Planning Survey, Pernambuco State, Brazil-1980. English language report.
  442. Maternal-child health and family planning survey, 1980, Bahia State, Brazil. [Pesquisa sobre saude materno-infantil e planejamento familiar 1980.]
  443. THe Matlab Family Planning Health Services Project (preliminary results on the demographic impact)
  444. Mauritius: A case study of the impact of family planning on fertility.
  445. Measurement issues involved in examining contraceptive use among young single women.
  446. Measurement of family planning program inputs in different program structures.
  447. Measurement of family planning programme inputs in different programme structures.
  448. Measurement of serum activity in short and long-term application of various hormonal contraceptives. [Serumaktivitatsmessungen bei Kurz- und Langzeitapplikation verschiedener hormonaler Kontrazeptiva.]
  449. Measures of efficiency for family planning evaluation programmes.
  450. Mechanical contraceptives--intra-uterine devices.
  451. Mechanism of action of contraceptive synthetic progestins.
  452. The mechanism of action of intrauterine contraceptive devices.
  453. Medicaid funding of family planning clinic services.
  454. Meeting the family planning needs of the urban poor.
  455. Men and family planning--a global view.
  456. Mennonite Central Committee Family Planning Program--Bangladesh.
  457. The metabolic effects of a low-estrogen/low-progestogen oral contraceptive.
  458. Metabolic effects of hormonal contraceptives.
  459. Metabolic effects of the birth control pill.
  460. Metrorrhagia in contraceptive users (author's transl) [Conduite a tenir en presence de metrorragies sous contraceptifs.]
  461. Mexico: marketing family planning. [Mexico: comercializacion de la planificacion familiar.]
  462. Micromixing of oral contraceptives.
  463. Mid-cycle contraception with LHRH in women.
  464. Midtrimester vaginal termination and concurrent contraception.
  465. Ministry of Justice issues circular on sanctions against people who sabotage birth control plans by removing women's intrauterine contraceptive devices.
  466. Minor illness or major disease? 18. Menstrual disorders, pregnancy and contraception. Screening and prescribing in the pharmacy.
  467. The minorities of Bukidnon. Roots and leaves remain the acceptable family planning device.
  468. Model for effective contraceptive counseling on campus.
  469. A model for evaluation of the Malaysian family planning programme.
  470. A model for the comparative analysis of WFS contraceptive use data.
  471. Modern contraceptive use in Indonesia: a challenge to conventional wisdom.
  472. Monitoring safety of contraceptive sterilization in developing countries: assessing mortality and morbidity.
  473. The moral development of black adolescents and its relationship to contraceptive use.
  474. Mortality in oral contraceptives users.
  475. Multiclinic study of a low-dose oral contraceptive.
  476. Myocardial infarction and oral contraceptives: has the risk changed?
  477. Myocardial infarction in a man handling oral contraceptives. Immunological study. [Infarctus du myocarde chez un homme manipulant des contraceptifs oraux. Etude immunologique.]
  478. Nasal absorption of natural contraceptive steroids in rats: progesterone absorption. [Letter]
  479. National experiences in analysis of costs, benefits and effectiveness of family planning.
  480. National meeting on birth control techniques ends.
  481. National strategy framework of population, human resource development and the family planning program.
  482. A national survey of fertility. No. 20. Sexual relations and contraception. The development of their social significance. [Une enquete nationale sur la fecondite. XX. Relations sexuelles et contraception. Evolution de leur signification sociale.]
  483. Natural and after contraception fertility. [Fertilite naturelle et apres contraception.]
  484. Natural and local contraception. [Contraception "naturelle" et contraception locale.]
  485. Natural Family Planning (NFP) Programme: All India Documentation and Evaluation Report (AIDER), January 1978 to December 1980.
  486. Natural family planning during breastfeeding.
  487. Natural family planning in India.
  488. Natural family planning in Mauritius: utilization patterns and predictors.
  489. Natural family planning. Pt. 3. Intermenstrual symptoms and estimated time of ovulation.
  490. Natural family planning. Pt. 4. The identification of postovulatory infertility.
  491. Natural family planning. [Letter]
  492. Natural family planning. [Letter]
  493. Natural family planning. [Naturalne planowanie rodziny.]
  494. Natural family planning: periodic abstinence as a method of fertility control.
  495. Natural family planning: unexpected benefits. charting cycles gives clues to moods and energy levels.
  496. Natural family planning: women deserve the truth.
  497. The need for a factory centered family planning program for all Egypt.
  498. Neoplasia and hormonal contraception.
  499. Nepal Contraceptive Prevalence Survey Report 1981 for Dang District.
  500. Nepal Contraceptive Prevalence Survey report 1981 for Gorkha District.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.